SK284868B6 - 1-Ar(alk)ylimidazolín-2-óny, spôsob ich prípravy, ich použitie a farmaceutický prostriedok s ich obsahom - Google Patents

1-Ar(alk)ylimidazolín-2-óny, spôsob ich prípravy, ich použitie a farmaceutický prostriedok s ich obsahom Download PDF

Info

Publication number
SK284868B6
SK284868B6 SK216-98A SK21698A SK284868B6 SK 284868 B6 SK284868 B6 SK 284868B6 SK 21698 A SK21698 A SK 21698A SK 284868 B6 SK284868 B6 SK 284868B6
Authority
SK
Slovakia
Prior art keywords
alk
ylimidazolin
chlorophenyl
morpholinoimidazolin
alkyl
Prior art date
Application number
SK216-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK21698A3 (en
Inventor
Hans-Joachim Lankau
Manfred Menzer
Klaus Unverferth
Karl Gewald
Harry Sch�Fer
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284868(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of SK21698A3 publication Critical patent/SK21698A3/sk
Publication of SK284868B6 publication Critical patent/SK284868B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK216-98A 1995-09-05 1996-07-26 1-Ar(alk)ylimidazolín-2-óny, spôsob ich prípravy, ich použitie a farmaceutický prostriedok s ich obsahom SK284868B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SK21698A3 SK21698A3 (en) 1998-10-07
SK284868B6 true SK284868B6 (sk) 2006-01-05

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
SK216-98A SK284868B6 (sk) 1995-09-05 1996-07-26 1-Ar(alk)ylimidazolín-2-óny, spôsob ich prípravy, ich použitie a farmaceutický prostriedok s ich obsahom

Country Status (32)

Country Link
EP (1) EP0863880B1 (bg)
JP (1) JP4030578B2 (bg)
CN (1) CN1103762C (bg)
AR (1) AR003502A1 (bg)
AT (1) ATE254606T1 (bg)
AU (1) AU700602B2 (bg)
BG (1) BG63917B1 (bg)
BR (1) BR9610359A (bg)
CA (1) CA2184871C (bg)
CZ (1) CZ291839B6 (bg)
DE (2) DE19532668A1 (bg)
DK (1) DK0863880T3 (bg)
EA (1) EA000535B1 (bg)
EE (1) EE03562B1 (bg)
ES (1) ES2208758T3 (bg)
FR (1) FR13C0049I2 (bg)
GE (1) GEP20022652B (bg)
HK (1) HK1015776A1 (bg)
HU (1) HU225956B1 (bg)
IL (1) IL123333A (bg)
LT (1) LT4482B (bg)
LU (1) LU92263I2 (bg)
NO (1) NO313829B1 (bg)
NZ (1) NZ315624A (bg)
PL (1) PL188287B1 (bg)
PT (1) PT863880E (bg)
SK (1) SK284868B6 (bg)
TR (1) TR199800476T1 (bg)
TW (1) TW422838B (bg)
UA (1) UA46790C2 (bg)
WO (1) WO1997009314A1 (bg)
ZA (1) ZA967014B (bg)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
EP2027856A1 (en) * 2003-07-11 2009-02-25 Boehringer Ingelheim Vetmedica Gmbh Method of treating or preventing central nervous system disorders with compounds having selectivity benzodiazepine receptor
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
EP2741736B1 (en) 2011-08-12 2017-11-22 Boehringer Ingelheim Vetmedica GmbH Taste masked pharmaceutical composition
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
PL188287B1 (pl) 2005-01-31
JPH11512101A (ja) 1999-10-19
EP0863880B1 (de) 2003-11-19
NZ315624A (en) 1998-11-25
NO980906D0 (no) 1998-03-02
CN1103762C (zh) 2003-03-26
GEP20022652B (en) 2002-03-25
WO1997009314A1 (de) 1997-03-13
TW422838B (en) 2001-02-21
IL123333A (en) 2001-10-31
EE03562B1 (et) 2001-12-17
EE9800063A (et) 1998-08-17
IL123333A0 (en) 1998-09-24
ES2208758T3 (es) 2004-06-16
HU225956B1 (en) 2008-01-28
HUP9802941A2 (hu) 1999-09-28
LU92263I2 (fr) 2013-10-07
TR199800476T1 (xx) 1998-06-22
BG63917B1 (bg) 2003-06-30
CZ291839B6 (cs) 2003-06-18
BR9610359A (pt) 1999-07-06
EA199800271A1 (ru) 1998-10-29
SK21698A3 (en) 1998-10-07
LT98047A (en) 1998-10-26
DK0863880T3 (da) 2004-03-22
JP4030578B2 (ja) 2008-01-09
ZA967014B (en) 1997-08-18
EA000535B1 (ru) 1999-10-28
HUP9802941A3 (en) 1999-10-28
CA2184871C (en) 2001-08-21
UA46790C2 (uk) 2002-06-17
HK1015776A1 (en) 1999-10-22
BG102287A (bg) 1998-09-30
FR13C0049I2 (fr) 2014-03-28
AU6737596A (en) 1997-03-27
NO980906L (no) 1998-03-02
DE19532668A1 (de) 1997-03-06
CZ66198A3 (cs) 1998-07-15
NO313829B1 (no) 2002-12-09
CN1200728A (zh) 1998-12-02
AU700602B2 (en) 1999-01-07
PT863880E (pt) 2004-04-30
CA2184871A1 (en) 1997-03-06
FR13C0049I1 (bg) 2013-09-27
DE59610827D1 (de) 2003-12-24
LT4482B (lt) 1999-03-25
AR003502A1 (es) 1998-08-05
ATE254606T1 (de) 2003-12-15
PL325413A1 (en) 1998-07-20
MX9801742A (es) 1998-08-30
EP0863880A1 (de) 1998-09-16

Similar Documents

Publication Publication Date Title
DE3888756T2 (de) Carbamoylpyrrolidonderivate, ihre Verwendung und Herstellung.
DE68918609T2 (de) Piperidinoalkyl-Derivate von Carbonsäure-Amiden.
US5164397A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in urinary therapeutics
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE1922003B2 (de) N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
SK284868B6 (sk) 1-Ar(alk)ylimidazolín-2-óny, spôsob ich prípravy, ich použitie a farmaceutický prostriedok s ich obsahom
CH641757A5 (en) O-Alkylated hydroxylamines and process for the preparation thereof
DE69115135T2 (de) 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.
US5869481A (en) Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
EP0412058A1 (en) 1-acyl-2-pyrrolidinones as enhancers of learning and memory and pharmaceutical compositions containing same
DE69310353T2 (de) 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze
EP0213326A1 (de) 2,5-Dimethylpyrrolderivative, ihre Herstellung und ihre Verwendung
CA2010529A1 (fr) Derives de la 1-arylsulfonyl 2-piperidinone, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions les renfermant
US6071911A (en) 4-amino-1-arylpyridin-2-ones and process for making
DE69405816T2 (de) Allophansäure Derivate
DE2511599A1 (de) Pyrroldiazepine und verfahren zu ihrer herstellung
DE69012407T2 (de) Imidazobenzodiazepine und ihre Salze, Verfahren zur Herstellung, Verwendung als Arzneimittel und diese Substanzen enthaltende Zusammensetzungen.
EP0287988A2 (de) Pyrrolaldehyde, ihre Herstellung und ihre Verwendung
EP0663395A1 (de) 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihrer Verwendung als herzfrequenzsenkendes Mittel
EP0338435A1 (de) 3.4-Dihydroxypyrrolidin-2-on-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung sowie die bei der Herstellung anfallenden Zwischenprodukte
LT4457B (lt) Nauji pasižymintys antispazminiu aktyvumu imidazolin-2,4-dionai, turintys orto-pakeistą aril(alkil)-radikalą 1 padėtyje, ir jų gavimo būdas
EP0001585A1 (de) Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen
AT265289B (de) Verfahren zur Herstellung von neuen Azepinderivaten sowie von ihren Additionssalzen mit anorganischen oder organischen Säuren
DE2720968A1 (de) Neue 1-acyl-2-hydroxy-1,3-diaminopropane, verfahren zu deren herstellung und arzneimittel
RU2128651C1 (ru) Н-бутиламид 2-анилино-6,7-дигидро-5н-пириндин-3-карбоновой кислоты, проявляющий противовоспалительную активность

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: BIOTIE THERAPIES GMBH, RADEBEUL, DE

Free format text: FORMER OWNER: ELBION AG, RADEBEUL, DE

Effective date: 20110426

PC4A Assignment and transfer of rights

Owner name: BIOCREA GMBH, RADEBEUL, DE

Free format text: FORMER OWNER: BIOTIE THERAPIES GMBH, RADEBEUL, DE

Effective date: 20110407

MK4A Patent expired

Expiry date: 20160726